Medizinische Universität Graz - Research portal
Selected Publication:
SHR Neuro Cancer Cardio Lipid Metab Microb
Holl-Wieden, A; Beer, M; Marx, A; Bonwg, R; Tappe, D; Girschick, HJ.
Infection of an urachal cyst during etanercept therapy in juvenile idiopathic arthritis
Rheumatol Int. 2008; 28(8):819-822
Doi: 10.1007/s00296-008-0521-z
(- Case Report)
Web of Science
PubMed
FullText
FullText_MUG
- Co-authors Med Uni Graz
- Beer Meinrad
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- Etanercept, a tumor necrosis factor (TNF) receptor alpha antagonist is licensed for the treatment in patients affected by polyarticular juvenile idiopathic arthritis, who do not tolerate or had an inadequate response to methotrexate. Infections related to immunosuppression by etanercept are of major concern. We report on a 17-year-old boy with enthesitis-related arthritis who developed a major infection of an urachal cyst 18 months after initiation of etanercept therapy, which required surgery. The urachus had not been symptomatic before.
- Find related publications in this database (using NLM MeSH Indexing)
- Adolescent -
- Arthritis, Juvenile Rheumatoid - complications Arthritis, Juvenile Rheumatoid - drug therapy
- Biopsy -
- Child -
- Humans -
- Immunoglobulin G - therapeutic use
- Infection - complications
- Male -
- Receptors, Tumor Necrosis Factor - therapeutic use
- Urachal Cyst - complications Urachal Cyst - pathology Urachal Cyst - ultrasonography
- Find related publications in this database (Keywords)
- urachus
- urachal infection
- TNF alpha blockade
- etanercept